190 related articles for article (PubMed ID: 36573482)
1. Prevention and therapy of chemotherapy-induced peripheral neuropathy: a review of recent findings.
Michalová Z; Székiová E; Blaško J; Vanický I
Neoplasma; 2023 Feb; 70(1):15-35. PubMed ID: 36573482
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced peripheral neuropathy: A current review.
Staff NP; Grisold A; Grisold W; Windebank AJ
Ann Neurol; 2017 Jun; 81(6):772-781. PubMed ID: 28486769
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-induced peripheral neuropathy - epidemiology and pathogenesis.
Iżycki D; Niezgoda A; Kaźmierczak M; Nowak-Markwitz E
Ginekol Pol; 2016; 87(4):293-9. PubMed ID: 27321102
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy-induced peripheral neuropathy: characteristics, diagnosis and treatment].
Istenes I; Nagy Z; Demeter J
Magy Onkol; 2016 Jun; 60(2):165-75. PubMed ID: 27275643
[TBL] [Abstract][Full Text] [Related]
5. A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy.
Molassiotis A; Suen LKP; Cheng HL; Mok TSK; Lee SCY; Wang CH; Lee P; Leung H; Chan V; Lau TKH; Yeo W
Integr Cancer Ther; 2019; 18():1534735419836501. PubMed ID: 30905173
[TBL] [Abstract][Full Text] [Related]
6. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.
Kandula T; Farrar MA; Cohn RJ; Mizrahi D; Carey K; Johnston K; Kiernan MC; Krishnan AV; Park SB
JAMA Neurol; 2018 Aug; 75(8):980-988. PubMed ID: 29799906
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced peripheral neuropathy.
Armstrong T; Almadrones L; Gilbert MR
Oncol Nurs Forum; 2005 Mar; 32(2):305-11. PubMed ID: 15759068
[TBL] [Abstract][Full Text] [Related]
9. [Peripheral neuropathy as a side effect of chemotherapy and targeted therapy].
Gießen-Jung C; von Baumgarten L
Dtsch Med Wochenschr; 2018 Jul; 113(13):970-978. PubMed ID: 29972842
[TBL] [Abstract][Full Text] [Related]
10. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.
Ocean AJ; Vahdat LT
Support Care Cancer; 2004 Sep; 12(9):619-25. PubMed ID: 15258838
[TBL] [Abstract][Full Text] [Related]
12. [Nursing care of chemotherapy-induced peripheral neuropathy].
Hsu SY; Lu CH; Chen SZ; Jane SW
Hu Li Za Zhi; 2015 Apr; 62(2):84-8. PubMed ID: 25854951
[TBL] [Abstract][Full Text] [Related]
13. The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP.
Streckmann F; Balke M; Lehmann HC; Rustler V; Koliamitra C; Elter T; Hallek M; Leitzmann M; Steinmetz T; Heinen P; Baumann FT; Bloch W
BMC Cancer; 2018 Jan; 18(1):62. PubMed ID: 29316888
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.
Kachrani R; Santana A; Rogala B; Pawasauskas J
J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):141-152. PubMed ID: 32118502
[TBL] [Abstract][Full Text] [Related]
15. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
Kuriyama A; Endo K
Support Care Cancer; 2018 Apr; 26(4):1051-1059. PubMed ID: 29280005
[TBL] [Abstract][Full Text] [Related]
16. The use of antioxidant agents for chemotherapy-induced peripheral neuropathy treatment in animal models.
Carvalho LF; Silva AMF; Carvalho AA
Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):971-979. PubMed ID: 28649767
[TBL] [Abstract][Full Text] [Related]
17. Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy.
Bakogeorgos M; Georgoulias V
Expert Rev Anticancer Ther; 2017 Nov; 17(11):1045-1060. PubMed ID: 28868935
[TBL] [Abstract][Full Text] [Related]
18. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
Amara S
Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
[TBL] [Abstract][Full Text] [Related]
19. Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial.
Clavo B; Martínez-Sánchez G; Rodríguez-Esparragón F; Rodríguez-Abreu D; Galván S; Aguiar-Bujanda D; Díaz-Garrido JA; Cañas S; Torres-Mata LB; Fabelo H; Téllez T; Santana-Rodríguez N; Fernández-Pérez L; Marrero-Callico G
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802143
[TBL] [Abstract][Full Text] [Related]
20. Challenges Evaluating Chemotherapy-Induced Peripheral Neuropathy in Childhood Cancer Survivors.
Mohrmann C; Armer J; Hayashi RJ
J Pediatr Oncol Nurs; 2017; 34(2):106-114. PubMed ID: 27251891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
